Indication:Cisplatin for Injection

Specification:10mg

Dosage Form:Powder

Active Ingredients:Cisplatin

Route of Administration:Intravenous Drip

Shelf Life:18 months

Storage:Protected from light

Package:negotiable

Qualification:Chinese GMP

Indication:DCETRIS Indications ADCETRIS® (brentuximab vedotin) is indicated for the treatment of: Previously untreated Stage III/IV classical Hodgkin lymphoma (cHL) Adult patients with previously untreated

Dosage Form:Injection

Active Ingredients:brentuximab vedotin

Route of Administration:Intravenous Drip

Shelf Life:18 months

Storage:2℃-8℃

Package:1 VIAL per pack

Place of Origin:EU

Qualification:EU GMP

Indication:Soliris is indicated for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH) to reduce hemolysis.

Dosage Form:Injection

Active Ingredients:Eculizumab

Route of Administration:Intravenous Drip

Shelf Life:18 months

Storage:2℃-8℃

Package:1 vial per carton

Place of Origin:EU

Qualification:EU GMP

Indication:For the treatment of advanced or metastatic renal cell cancer (RCC). For the first-line treatment of metastatic renal cell cancer (RCC).

Dosage Form:Capsule

Active Ingredients:cabozantinib

Route of Administration:Oral

Shelf Life:18 months

Storage:Below 25℃

Package:20/80mg 56 hard capsules

Place of Origin:EU

Qualification:EU GMP

Indication:Adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer

Dosage Form:Tablet

Route of Administration:Oral

Shelf Life:2 years

Storage:Sealed

Qualification:FDA

Indication:Stage D 2 metastatic carcinoma of the prostate.

Dosage Form:Tablet

Route of Administration:Oral

Shelf Life:2 years

Storage:Sealed

Qualification:FDA

Indication:Cyproterone 50 mg

Dosage Form:Tablet

Route of Administration:Oral

Shelf Life:2 years

Storage:Sealed

Qualification:FDA

Indication:Myeloid leukemia and head and neck cancers

Dosage Form:Capsule

Route of Administration:Oral

Shelf Life:2 years

Storage:Sealed

Qualification:FDA

Indication:used in the prevention and treatment of osteoporosis and metastasis-associated skeletal fractures in people with cancer.

Dosage Form:Tablet

Route of Administration:Oral

Shelf Life:2 years

Storage:Sealed

Qualification:FDA

Dosage Form:Injection

Route of Administration:Intramuscular Injection

Shelf Life:2 years

Storage:Sealed

Qualification:FDA

Dosage Form:Injection

Route of Administration:Intramuscular Injection

Shelf Life:2 years

Storage:Sealed

Qualification:FDA

Dosage Form:Injection

Route of Administration:Intramuscular Injection

Shelf Life:2 years

Storage:Sealed

Qualification:FDA

Dosage Form:Injection

Route of Administration:Intramuscular Injection

Shelf Life:2 years

Storage:Sealed

Qualification:FDA

Dosage Form:Injection

Route of Administration:Intramuscular Injection

Shelf Life:2 years

Storage:Sealed

Qualification:FDA

Dosage Form:Injection

Route of Administration:Intramuscular Injection

Shelf Life:2 years

Storage:Sealed

Qualification:FDA

Dosage Form:Injection

Route of Administration:Intramuscular Injection

Shelf Life:2 years

Storage:Sealed

Qualification:FDA